Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
H&R Block
HRB
$6.72B
| $15.5M | 0.01% |
590,865
-71,839
| -11% | -$1.86M |
|
1252
Molina Healthcare
MOH
$11B
| $15.5M | 0.01% |
201,786
-116,720
| -37% | -$8.42M |
|
1253
CALL
Ford
F
$56.3B
| $15.5M | 0.01% |
1,237,300
-1,932,800
| -61% | -$23.8M |
|
|
CY
1254
DELISTED
Cypress Semiconductor
CY
| $15.4M | 0.01% |
1,013,563
-6,298,194
| -86% | -$100M |
|
1255
Ziff Davis
ZD
$1.9B
| $15.4M | 0.01% |
236,690
-32,980
| -12% | -$2.15M |
|
1256
CALL
Cheniere Energy
LNG
$55.8B
| $15.4M | 0.01% |
286,400
+28,600
| +11% | +$1.38M |
|
|
P
1257
DELISTED
Pandora Media Inc
P
| $15.4M | 0.01% |
3,197,139
+2,858,684
| +845% | +$17.1M |
|
|
K
1258
CALL
DELISTED
Kellanova
K
| $15.4M | 0.01% |
241,116
+109,801
| +84% | +$6.61M |
|
1259
CALL
Signet Jewelers
SIG
$3.51B
| $15.4M | 0.01% |
272,100
+6,500
| +2% | +$397K |
|
1260
CALL
Agnico Eagle Mines
AEM
$94.4B
| $15.4M | 0.01% |
333,000
+111,800
| +51% | +$4.99M |
|
1261
PUT
BHP
BHP
$222B
| $15.4M | 0.01% |
374,302
-122,974
| -25% | -$4.63M |
|
|
CHK
1262
PUT
DELISTED
Chesapeake Energy Corporation
CHK
| $15.3M | 0.01% |
19,371
+562
| +3% | +$438K |
|
1263
HF Sinclair
DINO
$16.4B
| $15.3M | 0.01% |
299,450
-119,484
| -29% | -$5.05M |
|
1264
Assurant
AIZ
$13.9B
| $15.3M | 0.01% |
151,713
-249,943
| -62% | -$24.7M |
|
1265
PUT
Allstate
ALL
$65.7B
| $15.2M | 0.01% |
145,100
+53,000
| +58% | +$5.22M |
|
|
LTRPA
1266
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $15.2M | 0.01% |
1,607,627
+349,896
| +28% | +$3.59M |
|
|
LGF.A
1267
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $15.1M | 0.01% |
447,381
+124,686
| +39% | +$3.92M |
|
1268
CALL
Incyte
INCY
$24.2B
| $15.1M | 0.01% |
159,700
+55,200
| +53% | +$5.77M |
|
1269
Boston Scientific
BSX
$75.4B
| $15.1M | 0.01% |
609,765
-1,467,135
| -71% | -$40.5M |
|
1270
CALL
Sinclair Inc
SBGI
$1.06B
| $15.1M | 0.01% |
399,100
+152,000
| +62% | +$5.03M |
|
1271
PUT
Johnson Controls International
JCI
$92B
| $15.1M | 0.01% |
395,500
+246,900
| +166% | +$9.65M |
|
1272
CALL
Lumen
LUMN
$6.76B
| $15.1M | 0.01% |
903,600
+495,800
| +122% | +$8.41M |
|
1273
CALL
Align Technology
ALGN
$12.9B
| $15M | 0.01% |
67,700
+14,500
| +27% | +$3.29M |
|
|
DF
1274
DELISTED
Dean Foods Company
DF
| $15M | 0.01% |
1,300,694
+22,115
| +2% | +$235K |
|
1275
PUT
Vertex Pharmaceuticals
VRTX
$128B
| $15M | 0.01% |
100,200
-21,300
| -18% | -$3.15M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.